Werbung
Werbung
ATNM
Actinium Pharmaceuticals, Inc
1.38
USDGesponsert
-0.05
-3.29%
09. Jan., 15:59 UTC -5
Geschlossen
Nach-Markt
1.40
+0.02
+1.23%
ATNM Ergebnisberichte
Positives Überraschungsverhältnis
ATNM übertreffen die 23 der letzten 40Schätzungen.
57%
Nächster Bericht
Datum des nächsten Berichts
30. März 2026
Estimate for Q4 25 (Revenue/ EPS)
--
/-$0.19
Implizierte Änderung von Q3 25 (Revenue/ EPS)
-100.00%
/+18.75%
Implizierte Änderung von Q4 24 (Revenue/ EPS)
--
/-9.52%
Actinium Pharmaceuticals, Inc earnings per share and revenue
On 14. Nov. 2025, ATNM reported earnings of -0.16 USD per share (EPS) for Q3 25, beating the estimate of -0.32 USD, resulting in a 51.49% surprise. Revenue reached 90.00 tausend, compared to an expected --, with a 0.00% difference. The market reacted with a +14.17% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 6 analysts forecast an EPS of -0.19 USD, with revenue projected to reach -- USD, implying an increase of 18.75% EPS, and decrease of -100.00% in Revenue from the last quarter.
FAQ
What were Actinium Pharmaceuticals, Inc's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Actinium Pharmaceuticals, Inc reported EPS of -$0.16, beating estimates by 51.49%, and revenue of $90.00K, 0% as expectations.
How did the market react to Actinium Pharmaceuticals, Inc's Q3 2025 earnings?
The stock price moved up 14.17%, changed from $1.27 before the earnings release to $1.45 the day after.
When is Actinium Pharmaceuticals, Inc expected to report next?
The next earning report is scheduled for 30. März 2026.
What are the forecasts for Actinium Pharmaceuticals, Inc's next earnings report?
Based on 6
analysts, Actinium Pharmaceuticals, Inc is expected to report EPS of -$0.19 and revenue of -- for Q4 2025.
Which companies are reporting earnings today?
Scheck FXEmpire's Earnings Calendar for today's list of reporting companies.
Werbung